Delivery Order SPE2DE24D0013-SPE2D625F3BYY
- Not listed
- The U.S. Defense Department's Medical Supply Chain awarded a $8,640 firm fixed-price delivery order to Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, on September 9, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, is for diagnostic testing solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) detection, with performance completion targeted for September 16, 2025. The contract contains no set-aside designation and represents a...
- The U.S. Department of Defense's Medical Supply Chain awarded a $3,400 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, on September 10, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, is scheduled for completion by September 17, 2025, and carries no set-aside designation. The contract nomenclature indicates the order involves diagnostic testing solutions for COVID-19, influenza, and respiratory syncytial...
- The U.S. Department of Defense's Medical Supply Chain awarded a $13.6K firm fixed-price delivery order to Cepheid Inc. on September 4, 2025, with completion scheduled for September 11, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, procures molecular diagnostic testing solutions from the Sunnyvale, California-based manufacturer, likely supporting COVID-19, influenza, and respiratory syncytial virus (RSV) detection capabilities across military healthcare systems. The award carries no...
- The Defense Department's Medical Supply Chain awarded a $25,920 firm fixed-price delivery order to Cepheid Inc. on September 9, 2025, with an ultimate completion date of September 16, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, procures molecular diagnostic solutions from the Sunnyvale, California-based manufacturer, likely supporting testing capabilities for COVID-19, influenza, and respiratory syncytial virus (RSV) detection across federal healthcare systems. This award carries...
- The U.S. Defense Department's Medical Supply Chain awarded a $8,160 firm fixed-price delivery order to Cepheid Inc., a molecular diagnostic solutions manufacturer based in Sunnyvale, California, on September 2, 2025. This delivery order, designated 4569302270 for XPCOV2/FLU/RSV-10 testing solutions, is scheduled for completion by September 9, 2025, with work performed at the contractor's Sunnyvale facility. The award carries no small business set-aside designation and represents part of...
- The U.S. Defense Department's Medical Supply Chain awarded Cepheid Inc., a Sunnyvale, California-based molecular diagnostics manufacturer, a firm fixed-price delivery order valued at $20,400 on August 11, 2025, with an ultimate completion date of August 18, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, involves diagnostic testing solutions for COVID-19, influenza, and respiratory syncytial virus (RSV)—infectious diseases commonly detected through Cepheid's GeneXpert molecular...
- The Defense Department's Medical Supply Chain awarded a $17,280 firm fixed-price delivery order to Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, on September 3, 2025, with completion targeted for September 10, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, carries no set-aside designation and procures diagnostic testing solutions, likely reagents and assays for COVID-19, influenza, and respiratory syncytial virus detection based on the contract...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order valued at $2,040 to Cepheid Inc., a leading molecular diagnostics manufacturer based in Sunnyvale, California, on August 27, 2025. This firm fixed-price delivery order, designated 4569235830 and titled XPCOV2/FLU/RSV-10, is scheduled for completion by September 4, 2025, and carries no set-aside designation. The contract leverages Cepheid's expertise in advanced diagnostic systems and test kits, with the product...
- The Defense Department's Medical Supply Chain division awarded Cepheid Inc. a $17,952 firm fixed-price delivery order on August 4, 2025, for molecular diagnostic solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) testing. The contract is set to be completed by August 18, 2025, with performance taking place at Cepheid's headquarters in Sunnyvale, California. This delivery order represents a continuation of the Defense Department's reliance on Cepheid's GeneXpert...
- The U.S. Defense Logistics Agency, operating under the Medical Supply Chain office, awarded a firm fixed-price delivery order valued at $8,840 to Cepheid Inc. on July 29, 2025, with an ultimate completion date of August 5, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, procures molecular diagnostic testing solutions, specifically reagents and test kits for detecting COVID-19, influenza, and respiratory syncytial virus (RSV). The contract carries no set-aside designation and will be...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F3BYYDelivery Order
The Department of Defense's Medical Supply Chain awarded a $8,640 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, on September 10, 2025, with completion scheduled for September 17, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, procures diagnostic testing capabilities for COVID-19, influenza, and respiratory syncytial virus (RSV)—critical infectious disease detection capabilities aligned with DoD's health security requirements. The contract involves no small business set-aside and reflects Cepheid's established position as a federal supplier of GeneXpert diagnostic systems and associated molecular reagent kits used across multiple federal healthcare networks. This award likely represents a task order or renewal drawn from one of Cepheid's two significant indefinite delivery vehicle contracts with the Department of Veterans Affairs, which collectively provide access to the company's molecular diagnostic testing platforms. Cepheid's substantial IDV vehicles—valued at $32.8 million with VA's Veterans Integrated Service Network 6 and $2.5 million with Veterans Integrated Service Network 21—establish the company as a primary federal provider of PCR-based testing for infectious disease detection. The modest award value and short performance timeline suggest this delivery order addresses immediate operational requirements for respiratory pathogen diagnostics within the DoD medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.6k | 9/10/25 |